Innovation in container closer systems and aseptic processing for ATMPs
The pharmaceutical landscape is shifting from blockbuster drugs to personalized treatments, driving the need for innovative container closure systems. This […]
The pharmaceutical landscape is shifting from blockbuster drugs to personalized treatments, driving the need for innovative container closure systems. This […]
Nancy McGee, VP & GM, U.S. Patient Support Services, IQVIA Jennifer Millard, VP, U.S. Integrated Patient Support Services, IQVIA For
Maguire’s complaint indicates that she began receiving Depo-Provera injections in 1996, shortly after its release, and continued the quarterly treatments
Clinical trials are increasingly complex, with growing data points, forms, and rules. How can sponsors and CROs balance this surge
Top 5 Bioproduction Considerations When Scaling Your Therapeutic Program to the Clinic and Beyond Learn 5 key strategies to optimize
Rolf indicates he became addicted to opioids that were originally prescribed for pain management, and was then prescribed Suboxone film
Jeroen de Groot is a highly accomplished R&D and business executive who has an extensive background leading international contract research
For this latest study, researchers from the National Institutes of Environmental Health Sciences, led by Dr. Kyla W. Taylor, performed
Early in the MDL proceedings, Judge Durkin established a Tepezza “bellwether” program, where a group of 12 representative cases were
Fuel Life Sciences Innovation and Discovery If your data management and storage infrastructure has gaps in Findability, Accessibility, Interoperability and